Analyst Ratings for Moderna (MRNA) [Buys]

MRNA Rating Summary

MRNA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MRNA
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $162.46 (-25.8%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/13/2020 Brookline Capital Markets
» Updated 6/8/2021
Leah Rush Cann New Coverage Buy
(N/A)
224.00
(205.00)
62.61
(218.85)
249.54% Details
6/30/2020 Argus
» Updated 12/1/2020
John Eade New Coverage Buy
(N/A)
200.00
(88.00)
62.08
(218.85)
252.53% Details
Like MRNA Ratings? Also take a look at PFE, AZN, JNJ, BNTX

MRNA Ratings News